BIOMAT Database Logo BIOMAT Database Logo

Rapsyn antibodies in myasthenia gravis. 1998

M A Agius, and S Zhu, and C A Kirvan, and A L Schafer, and M Y Lin, and R H Fairclough, and J J Oger, and T Aziz, and J A Aarli
Department of Neurology, University of California at Davis 95616, USA.

UI MeSH Term Description Entries
D009124 Muscle Proteins The protein constituents of muscle, the major ones being ACTINS and MYOSINS. More than a dozen accessory proteins exist including TROPONIN; TROPOMYOSIN; and DYSTROPHIN. Muscle Protein,Protein, Muscle,Proteins, Muscle
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D009222 Myotonia Prolonged failure of muscle relaxation after contraction. This may occur after voluntary contractions, muscle percussion, or electrical stimulation of the muscle. Myotonia is a characteristic feature of MYOTONIC DISORDERS. Myotonic Phenomenon,Percussion Myotonia,Myotonia, Percussion,Myotonias,Myotonias, Percussion,Myotonic Phenomenons,Percussion Myotonias,Phenomenon, Myotonic,Phenomenons, Myotonic
D011917 Rats, Inbred Lew An inbred strain of rat that is used in BIOMEDICAL RESEARCH. Rats, Inbred Lewis,Rats, Lew,Inbred Lew Rat,Inbred Lew Rats,Inbred Lewis Rats,Lew Rat,Lew Rat, Inbred,Lew Rats,Lew Rats, Inbred,Lewis Rats, Inbred,Rat, Inbred Lew,Rat, Lew
D011950 Receptors, Cholinergic Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology. ACh Receptor,Acetylcholine Receptor,Acetylcholine Receptors,Cholinergic Receptor,Cholinergic Receptors,Cholinoceptive Sites,Cholinoceptor,Cholinoceptors,Receptors, Acetylcholine,ACh Receptors,Receptors, ACh,Receptor, ACh,Receptor, Acetylcholine,Receptor, Cholinergic,Sites, Cholinoceptive
D011978 Receptors, Nicotinic One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into muscle-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors. Nicotinic Acetylcholine Receptors,Nicotinic Receptors,Nicotinic Acetylcholine Receptor,Nicotinic Receptor,Acetylcholine Receptor, Nicotinic,Acetylcholine Receptors, Nicotinic,Receptor, Nicotinic,Receptor, Nicotinic Acetylcholine,Receptors, Nicotinic Acetylcholine
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D002819 Chorea Involuntary, forcible, rapid, jerky movements that may be subtle or become confluent, markedly altering normal patterns of movement. Hypotonia and pendular reflexes are often associated. Conditions which feature recurrent or persistent episodes of chorea as a primary manifestation of disease are referred to as CHOREATIC DISORDERS. Chorea is also a frequent manifestation of BASAL GANGLIA DISEASES. Choreatic Disorders,Choreiform Movement,Chorea Disorders,Chorea Syndromes,Chorea, Benign Hereditary,Chorea, Chronic Progressive,Chorea, Rheumatic,Chorea, Senile,Chorea, Sydenham,Choreatic Syndromes,Choreic Movement,Dyskinesias, Paroxysmal,Hereditary Chorea,Hereditary Progressive Chorea Without Dementia,Paroxysmal Dyskinesias,Rheumatic Chorea,Senile Chorea,St. Vitus's Dance,Sydenham Chorea,Sydenham's Chorea,Benign Hereditary Chorea,Benign Hereditary Choreas,Chorea Disorder,Chorea Syndrome,Chorea, Hereditary,Chorea, Sydenham's,Choreas,Choreas, Benign Hereditary,Choreas, Chronic Progressive,Choreas, Hereditary,Choreas, Rheumatic,Choreas, Senile,Choreas, Sydenham,Choreatic Disorder,Choreatic Syndrome,Choreic Movements,Choreiform Movements,Chronic Progressive Chorea,Chronic Progressive Choreas,Disorder, Chorea,Disorder, Choreatic,Disorders, Chorea,Disorders, Choreatic,Dyskinesia, Paroxysmal,Hereditary Chorea, Benign,Hereditary Choreas,Hereditary Choreas, Benign,Movement, Choreic,Movement, Choreiform,Movements, Choreic,Movements, Choreiform,Paroxysmal Dyskinesia,Progressive Chorea, Chronic,Progressive Choreas, Chronic,Rheumatic Choreas,Senile Choreas,St. Vitus Dance,St. Vitus's Dances,St. Vituss Dance,Sydenham Choreas,Sydenhams Chorea,Syndrome, Chorea,Syndrome, Choreatic,Syndromes, Chorea,Syndromes, Choreatic
D004557 Electric Organ In about 250 species of electric fishes, modified muscle fibers forming disklike multinucleate plates arranged in stacks like batteries in series and embedded in a gelatinous matrix. A large torpedo ray may have half a million plates. Muscles in different parts of the body may be modified, i.e., the trunk and tail in the electric eel, the hyobranchial apparatus in the electric ray, and extrinsic eye muscles in the stargazers. Powerful electric organs emit pulses in brief bursts several times a second. They serve to stun prey and ward off predators. A large torpedo ray can produce of shock of more than 200 volts, capable of stunning a human. (Storer et al., General Zoology, 6th ed, p672) Electric Organs,Organ, Electric,Organs, Electric

Related Publications

M A Agius, and S Zhu, and C A Kirvan, and A L Schafer, and M Y Lin, and R H Fairclough, and J J Oger, and T Aziz, and J A Aarli
Myasthenia gravis AChR antibodies inhibit function of rapsyn-clustered AChRs.
May 2020, Journal of neurology, neurosurgery, and psychiatry,
M A Agius, and S Zhu, and C A Kirvan, and A L Schafer, and M Y Lin, and R H Fairclough, and J J Oger, and T Aziz, and J A Aarli
[Antibodies in myasthenia gravis].
February 2009, Revue neurologique,
M A Agius, and S Zhu, and C A Kirvan, and A L Schafer, and M Y Lin, and R H Fairclough, and J J Oger, and T Aziz, and J A Aarli
Myasthenia gravis: antibodies to acetylcholine receptor in ocular myasthenia gravis.
January 1981, Journal of neurology,
M A Agius, and S Zhu, and C A Kirvan, and A L Schafer, and M Y Lin, and R H Fairclough, and J J Oger, and T Aziz, and J A Aarli
[Myasthenia gravis (2). Antibodies against acetylcholinergic receptros in myasthenia gravis].
October 1978, Lakartidningen,
M A Agius, and S Zhu, and C A Kirvan, and A L Schafer, and M Y Lin, and R H Fairclough, and J J Oger, and T Aziz, and J A Aarli
Autoantiidiotypic antibodies in myasthenia gravis.
January 1987, Annals of the New York Academy of Sciences,
M A Agius, and S Zhu, and C A Kirvan, and A L Schafer, and M Y Lin, and R H Fairclough, and J J Oger, and T Aziz, and J A Aarli
Muscle antibodies in myasthenia gravis.
September 1967, Immunology,
M A Agius, and S Zhu, and C A Kirvan, and A L Schafer, and M Y Lin, and R H Fairclough, and J J Oger, and T Aziz, and J A Aarli
Anticollagen antibodies in myasthenia gravis.
January 1988, Revista do Hospital das Clinicas,
M A Agius, and S Zhu, and C A Kirvan, and A L Schafer, and M Y Lin, and R H Fairclough, and J J Oger, and T Aziz, and J A Aarli
Muscle antibodies in myasthenia gravis.
January 1970, Acta neurologica Scandinavica,
M A Agius, and S Zhu, and C A Kirvan, and A L Schafer, and M Y Lin, and R H Fairclough, and J J Oger, and T Aziz, and J A Aarli
Antivirus antibodies in myasthenia gravis.
September 1985, Neurology,
M A Agius, and S Zhu, and C A Kirvan, and A L Schafer, and M Y Lin, and R H Fairclough, and J J Oger, and T Aziz, and J A Aarli
[Pathogenic antibodies in myasthenia gravis].
April 2010, Brain and nerve = Shinkei kenkyu no shinpo,
Copied contents to your clipboard!